Literature DB >> 19656875

Venezuelan equine encephalitis virus disrupts STAT1 signaling by distinct mechanisms independent of host shutoff.

Jason D Simmons1, Laura J White, Thomas E Morrison, Stephanie A Montgomery, Alan C Whitmore, Robert E Johnston, Mark T Heise.   

Abstract

Venezuelan equine encephalitis virus (VEEV) is an important human and veterinary pathogen causing sporadic epizootic outbreaks of potentially fatal encephalitis. The type I interferon (IFN) system plays a central role in controlling VEEV and other alphavirus infections, and IFN evasion is likely an important determinant of whether these viruses disseminate and cause disease within their hosts. Alphaviruses are thought to limit the induction of type I IFNs and IFN-stimulated genes by shutting off host cell macromolecular synthesis, which in the case of VEEV is partially mediated by the viral capsid protein. However, more specific strategies by which alphaviruses inhibit type I IFN signaling have not been characterized. Analyses of cells infected with VEEV and VEEV replicon particles (VRP) demonstrate that viral infection rapidly disrupts tyrosine phosphorylation and nuclear translocation of the transcription factor STAT1 in response to both IFN-beta and IFN-gamma. This effect was independent of host shutoff and expression of viral capsid, suggesting that VEEV uses novel mechanisms to interfere with type I and type II IFN signaling. Furthermore, at times when STAT1 activation was efficiently inhibited, VRP infection did not limit tyrosine phosphorylation of Jak1, Tyk2, or STAT2 after IFN-beta treatment but did inhibit Jak1 and Jak2 activation in response to IFN-gamma, suggesting that VEEV interferes with STAT1 activation by the type I and II receptor complexes through distinct mechanisms. Identification of the viral requirements for this novel STAT1 inhibition will further our understanding of alphavirus molecular pathogenesis and may provide insights into effective alphavirus-based vaccine design.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19656875      PMCID: PMC2753124          DOI: 10.1128/JVI.01041-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  59 in total

1.  Stat2 binding to the interferon-alpha receptor 2 subunit is not required for interferon-alpha signaling.

Authors:  Vinh-Phúc Nguyen; Abu Z M Saleh; Allison E Arch; Hai Yan; Flavia Piazza; John Kim; John J Krolewski
Journal:  J Biol Chem       Date:  2002-01-10       Impact factor: 5.157

2.  Mutations in the E2 glycoprotein of Venezuelan equine encephalitis virus confer heparan sulfate interaction, low morbidity, and rapid clearance from blood of mice.

Authors:  K A Bernard; W B Klimstra; R E Johnston
Journal:  Virology       Date:  2000-10-10       Impact factor: 3.616

Review 3.  Stats: transcriptional control and biological impact.

Authors:  David E Levy; J E Darnell
Journal:  Nat Rev Mol Cell Biol       Date:  2002-09       Impact factor: 94.444

4.  The protein tyrosine kinase JAK1 complements defects in interferon-alpha/beta and -gamma signal transduction.

Authors:  M Müller; J Briscoe; C Laxton; D Guschin; A Ziemiecki; O Silvennoinen; A G Harpur; G Barbieri; B A Witthuhn; C Schindler
Journal:  Nature       Date:  1993-11-11       Impact factor: 49.962

5.  A single amino acid change in the nuclear localization sequence of the nsP2 protein affects the neurovirulence of Semliki Forest virus.

Authors:  John K Fazakerley; Amanda Boyd; Marja L Mikkola; Leevi Kääriäinen
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

6.  Roles of nonstructural protein nsP2 and Alpha/Beta interferons in determining the outcome of Sindbis virus infection.

Authors:  Elena I Frolova; Rafik Z Fayzulin; Susan H Cook; Diane E Griffin; Charles M Rice; Ilya Frolov
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

7.  Role of alpha/beta interferon in Venezuelan equine encephalitis virus pathogenesis: effect of an attenuating mutation in the 5' untranslated region.

Authors:  L J White; J G Wang; N L Davis; R E Johnston
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

8.  The use of chimeric Venezuelan equine encephalitis viruses as an approach for the molecular identification of natural virulence determinants.

Authors:  A M Powers; A C Brault; R M Kinney; S C Weaver
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

9.  p135tyk2, an interferon-alpha-activated tyrosine kinase, is physically associated with an interferon-alpha receptor.

Authors:  O R Colamonici; H Uyttendaele; P Domanski; H Yan; J J Krolewski
Journal:  J Biol Chem       Date:  1994-02-04       Impact factor: 5.157

Review 10.  Venezuelan equine encephalitis.

Authors:  Scott C Weaver; Cristina Ferro; Roberto Barrera; Jorge Boshell; Juan-Carlos Navarro
Journal:  Annu Rev Entomol       Date:  2004       Impact factor: 19.686

View more
  42 in total

1.  Treatment with cationic liposome-DNA complexes (CLDCs) protects mice from lethal Western equine encephalitis virus (WEEV) challenge.

Authors:  Christopher H Logue; Aaron T Phillips; Eric C Mossel; Jeremy P Ledermann; Thomas Welte; Steve W Dow; Ken E Olson; Ann M Powers
Journal:  Antiviral Res       Date:  2010-05-07       Impact factor: 5.970

2.  Interferon-alpha/beta deficiency greatly exacerbates arthritogenic disease in mice infected with wild-type chikungunya virus but not with the cell culture-adapted live-attenuated 181/25 vaccine candidate.

Authors:  Christina L Gardner; Crystal W Burke; Stephen T Higgs; William B Klimstra; Kate D Ryman
Journal:  Virology       Date:  2012-02-01       Impact factor: 3.616

3.  Infected dendritic cells are sufficient to mediate the adjuvant activity generated by Venezuelan equine encephalitis virus replicon particles.

Authors:  Daniel R Tonkin; Alan Whitmore; Robert E Johnston; Mario Barro
Journal:  Vaccine       Date:  2012-04-21       Impact factor: 3.641

4.  The C-terminal domain of chikungunya virus nsP2 independently governs viral RNA replication, cytopathicity, and inhibition of interferon signaling.

Authors:  Jelke J Fros; Erika van der Maten; Just M Vlak; Gorben P Pijlman
Journal:  J Virol       Date:  2013-07-17       Impact factor: 5.103

Review 5.  Insect antiviral innate immunity: pathways, effectors, and connections.

Authors:  Megan B Kingsolver; Zhijing Huang; Richard W Hardy
Journal:  J Mol Biol       Date:  2013-10-09       Impact factor: 5.469

6.  A mouse model of chikungunya virus-induced musculoskeletal inflammatory disease: evidence of arthritis, tenosynovitis, myositis, and persistence.

Authors:  Thomas E Morrison; Lauren Oko; Stephanie A Montgomery; Alan C Whitmore; Alina R Lotstein; Bronwyn M Gunn; Susan A Elmore; Mark T Heise
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

7.  Chikungunya virus nonstructural protein 2 inhibits type I/II interferon-stimulated JAK-STAT signaling.

Authors:  Jelke J Fros; Wen Jun Liu; Natalie A Prow; Corinne Geertsema; Maarten Ligtenberg; Dana L Vanlandingham; Esther Schnettler; Just M Vlak; Andreas Suhrbier; Alexander A Khromykh; Gorben P Pijlman
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

8.  Early events in alphavirus replication determine the outcome of infection.

Authors:  Ilya Frolov; Maryna Akhrymuk; Ivan Akhrymuk; Svetlana Atasheva; Elena I Frolova
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

9.  Alpha interferon and not gamma interferon inhibits salmonid alphavirus subtype 3 replication in vitro.

Authors:  Cheng Xu; Tz-Chun Guo; Stephen Mutoloki; Øyvind Haugland; Inderjit S Marjara; Øystein Evensen
Journal:  J Virol       Date:  2010-06-23       Impact factor: 5.103

10.  Modulation of type I IFN induction by a virulence determinant within the alphavirus nsP1 protein.

Authors:  Catherine C Cruz; Mehul S Suthar; Stephanie A Montgomery; Reed Shabman; Jason Simmons; Robert E Johnston; Thomas E Morrison; Mark T Heise
Journal:  Virology       Date:  2010-01-25       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.